lapatinib has been researched along with fluorescein-5-isothiocyanate in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Chen, X; Gao, X; Li, Q; Li, Y; Luo, H; Wei, X; Westover, KD; Zhang, Y; Zhou, Z; Zhu, J | 1 |
1 other study(ies) available for lapatinib and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Dynamic ultrasound molecular-targeted imaging of senescence in evaluation of lapatinib resistance in HER2-positive breast cancer.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Fluorescein-5-isothiocyanate; Humans; Lapatinib; Receptor, ErbB-2; Ultrasonography | 2023 |